BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22222784)

  • 21. Antibody, complement and accommodation in ABO-incompatible transplants.
    King KE; Warren DS; Samaniego-Picota M; Campbell-Lee S; Montgomery RA; Baldwin WM
    Curr Opin Immunol; 2004 Oct; 16(5):545-9. PubMed ID: 15341997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody-mediated rejection: treatment alternatives and outcomes.
    Singh N; Pirsch J; Samaniego M
    Transplant Rev (Orlando); 2009 Jan; 23(1):34-46. PubMed ID: 19027615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy of antigen-specific immunoadsorption and rebound of anti-A/B antibodies in ABO-incompatible kidney transplantation.
    Genberg H; Kumlien G; Wennberg L; Tyden G
    Nephrol Dial Transplant; 2011 Jul; 26(7):2394-400. PubMed ID: 21558429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heart transplantation across antibodies against human leukocyte antigen and ABO-post-transplant follow-up of donor reactive antibodies.
    Bućin D; Johansson S; Lindberg LO
    Xenotransplantation; 2006 Mar; 13(2):101-4. PubMed ID: 16623800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-donor HLA class I antibodies: pathways to endothelial cell activation and cell-mediated allograft rejection.
    Naemi FM; Carter V; Kirby JA; Ali S
    Transplantation; 2013 Aug; 96(3):258-66. PubMed ID: 23823649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neither pre-transplant rituximab nor splenectomy affects de novo HLA antibody production after renal transplantation.
    Ashimine S; Watarai Y; Yamamoto T; Hiramitsu T; Tsujita M; Nanmoku K; Goto N; Takeda A; Katayama A; Uchida K; Kobayashi T
    Kidney Int; 2014 Feb; 85(2):425-30. PubMed ID: 23945498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of complement component 4d immunohistochemistry to ABO-compatible and ABO-incompatible liver transplantation.
    Salah A; Fujimoto M; Yoshizawa A; Yurugi K; Miyagawa-Hayashino A; Sumiyoshi S; Minamiguchi S; Uemoto S; Maekawa T; Haga H
    Liver Transpl; 2014 Feb; 20(2):200-9. PubMed ID: 24470446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular deciphering of the ABO system as a basis for novel diagnostics and therapeutics in ABO incompatible transplantation.
    Holgersson J; Rydberg L; Breimer ME
    Int Rev Immunol; 2014; 33(3):174-94. PubMed ID: 24350817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complement-binding anti-HLA antibodies and kidney-allograft survival.
    Loupy A; Lefaucheur C; Vernerey D; Prugger C; Duong van Huyen JP; Mooney N; Suberbielle C; Frémeaux-Bacchi V; Méjean A; Desgrandchamps F; Anglicheau D; Nochy D; Charron D; Empana JP; Delahousse M; Legendre C; Glotz D; Hill GS; Zeevi A; Jouven X
    N Engl J Med; 2013 Sep; 369(13):1215-26. PubMed ID: 24066742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of complement-fixing and non-fixing antibodies specific for endothelial precursor cells and lymphocytes using flow cytometry.
    AlMahri A; Holgersson J; Alheim M
    Tissue Antigens; 2012 Nov; 80(5):404-15. PubMed ID: 22931381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody-mediated rejection without acute graft dysfunction in adult ABO-compatible heart transplantation: a case of accommodation.
    Angelini A; Castellani C; Poli F; Benazzi E; Torregrossa G; Tona F; Gambino A; Caforio AP; Feltrin G; Toscano G; Valente M; Thiene G; Gerosa G
    J Heart Lung Transplant; 2008 Dec; 27(12):1357-60. PubMed ID: 19059119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-HLA antibodies can induce endothelial cell survival or proliferation depending on their concentration.
    Jindra PT; Zhang X; Mulder A; Claas F; Veale J; Jin YP; Reed EF
    Transplantation; 2006 Jul; 82(1 Suppl):S33-5. PubMed ID: 16829793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.
    Tait BD; Süsal C; Gebel HM; Nickerson PW; Zachary AA; Claas FH; Reed EF; Bray RA; Campbell P; Chapman JR; Coates PT; Colvin RB; Cozzi E; Doxiadis II; Fuggle SV; Gill J; Glotz D; Lachmann N; Mohanakumar T; Suciu-Foca N; Sumitran-Holgersson S; Tanabe K; Taylor CJ; Tyan DB; Webster A; Zeevi A; Opelz G
    Transplantation; 2013 Jan; 95(1):19-47. PubMed ID: 23238534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful unintentional ABO-incompatible renal transplantation: Blood group A1B donor into an A2B recipient.
    Fadeyi EA; Stratta RJ; Farney AC; Pomper GJ
    Am J Clin Pathol; 2014 May; 141(5):724-6. PubMed ID: 24713746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequent development of subclinical chronic antibody-mediated rejection within 1 year after renal transplantation with pre-transplant positive donor-specific antibodies and negative CDC crossmatches.
    Yamanaga S; Watarai Y; Yamamoto T; Tsujita M; Hiramitsu T; Nanmoku K; Goto N; Takeda A; Morozumi K; Katayama A; Saji H; Uchida K; Kobayashi T
    Hum Immunol; 2013 Sep; 74(9):1111-8. PubMed ID: 23792054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of accommodation in a sensitized human leukocyte antigen transgenic murine cardiac transplant model.
    Fukami N; Ramachandran S; Narayanan K; Liu W; Nath DS; Jendrisak M; Chapman W; Mohanakumar T
    Transplantation; 2012 Feb; 93(4):364-72. PubMed ID: 22273841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-glutathione S-transferase T1 antibody-mediated rejection in C4d-positive renal allograft recipients.
    Aguilera I; Alvarez-Marquez A; Gentil MA; Fernandez-Alonso J; Fijo J; Saez C; Wichmann I; Nuñez-Roldan A
    Nephrol Dial Transplant; 2008 Jul; 23(7):2393-8. PubMed ID: 18308775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood group O recipients associated with early graft deterioration in living ABO-incompatible kidney transplantation.
    Toki D; Ishida H; Horita S; Yamaguchi Y; Tanabe K
    Transplantation; 2009 Nov; 88(10):1186-93. PubMed ID: 19935372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kidney transplantation across HLA and ABO antibody barriers.
    Becker LE; Süsal C; Morath C
    Curr Opin Organ Transplant; 2013 Aug; 18(4):445-54. PubMed ID: 23838650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelial chimerism after ABO-incompatible kidney transplantation.
    Tanabe T; Ishida H; Horita S; Honda K; Yamaguchi Y; Nonomura K; Tanabe K
    Transplantation; 2012 Apr; 93(7):709-16. PubMed ID: 22456486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.